Respiratory allergies and COVID-19: an investigation of the clinical coexistence and its relation to complementary practice prevention and treatment
DOI:
https://doi.org/10.33448/rsd-v11i16.38267Keywords:
Comorbities; Chronical diseases; COVID-19; Probiotics.Abstract
After WHO declared the COVID-19’s pandemic at 2020, they sought to clarify the relation between risk and protection factors for the disease, among them, obesity, respiratory diseases, metabolic diseases and cardiovascular diseases. This study sought to relate chronical comorbidities with the gravity of the symptoms caused by the pandemic diseases. In addition, they investigated habits like the use of probiotics for the amenization of the allergic symptoms and the impact at the symptomatology of COVID-19. It´s about an original transversal epidemiologic study, analyzed through an online questionary with 550 participants above 18 years old, who agreed to the Free and clarified consentient terms. It was concluded that being in a family with a rent of 4 or more minimal wages and living with friends have an oppositive relation with the gravity of COVID-19 symptoms, while has a rent less than a minimal wage related with higher risks. Non transmissible chronical diseases like overweight/ obesity, hypercholesterolemia, hypertriglyceridemia, chronic arterial hypertension and anemia are related to a worse prognosis of the disease. No significative relevance was obtained between the gravity of the symptoms and de chronical respiratory diseases, not even any relation with the use of the probiotics.
References
Andrade, E. D. O. (2007). Validação do questionário de triagem de asma do inquérito de saúde respiratória da Comunidade Européia (ECRHS) na cidade de Manaus-AM.
Assis, E. D. C., Almeida, G. S., Nunes, I. C., De Carvalho, J. M. K., Cardoso, D. C. N., Barreto, B. B., Leal, M. B., De Oliveira, R. M. J., & Matos, C. S. (2022). Evidências científicas em medicinas tradicionais, práticas integrativas e complementares em saúde: investimento em pesquisa e perspectivas do ministério da saúde do Brasil. Revista Brasileira de Biomedicina, 2(1), 117–134. https://doi.org/http://dx.doi.org/10.5281/zenodo.6946197
Brasil. (2010). Departamento de atenção básica. Cadernos de Atenção Básica: Doenças Respiratórias Crônicas (25th ed.). Ministério da Saúde.
Centers for Disease Control and Prevention (2020). Preliminary Estimates of the Prevalence of Selected UnderlyingHealth Conditions Among Patients with Coronavirus Disease 2019 United States. MMWR Morb Mortal Wkly, 69(13), 382–386. http://dx.doi.org/10.15585/mmwr.mm6913e2
Crovesy, L., Gongalves, D., & Trigo, E. L. (2017). Probióticos en el tratamiento de alergias: una revisión. Revista Española De Nutrición Humana Y Dietética, 21(3), 293–299. https://dx.doi.org/10.14306/renhyd.21.3.361
Carvalho, J., Serviço de Imunoalergologia, Centro Hospitalar Universitário de Coimbra, Coutinho, I., Nunes, I., Moura, A., Regateiro, F., Serviço de Imunoalergologia, Centro Hospitalar Universitário de Coimbra, Instituto de Imunologia, Faculdade de Medicina, Universidade de Coimbra, & Coimbra Institute for Clinical and Biomedical Reseach (iCBR), Faculdade de Medicina, Universidade de Coimbra. (2020). Asma e COVID-19: Atualização. Revista Portuguesa de Imunoalergologia, 28(2). https://doi.org/10.32932/rpia.2020.06.034
CDC updates, expands list of people at risk of severe COVID-19 illness. (2020, June 25). Centers for Disease Control and Prevention. https://www.cdc.gov/media/releases/2020/p0625-update-expands-covid-19.html
Em pacientes da COVID-19, quais são os sintomas e características clínicas dos casos leves e moderados? (n.d.). Oxford Brazil EBM Alliance. Retrieved November 28, 2022, from https://oxfordbrazilebm.com/index.php/em-pacientes-da-covid-19-quais-sao-os-sintomas-e-caracteristicas-clinicas-dos-casos-leves-e-moderados/
Facts and stats - 50 million Americans have allergies. (2020, October 26). ACAAI Public Website. https://acaai.org/news/facts-statistics/allergies
Fernandes, S. de S. C., Andrade, C. R. de, Alvim, C. G., Camargos, P. A. M., & Ibiapina, C. da C. (2017). Epidemiological trends of allergic diseases in adolescents. Jornal Brasileiro de Pneumologia: Publicacao Oficial Da Sociedade Brasileira de Pneumologia e Tisilogia, 43(5), 368–372. https://doi.org/10.1590/s1806-37562016000000255
Gov.Br. Retrieved November 28, 2022, from https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/p/praticas-integrativas-e-complementares-pics-1
Hartmann-Boyce, J., Gunnell, J., Drake, J., Otunla, A., Suklan, J., Schofield, E., Kinton, J., Inada-Kim, M., Hobbs, F. D. R., & Dennison, P. (2020). Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evidence-Based Medicine, 26(4), 195–195. https://doi.org/10.1136/bmjebm-2020-111506
Hallal, P. C. (2020). Evolução da prevalência de infecção por COVID-19 no Rio Grande do Sul, Brasil: inquéritos sorológicos seriados. Ciência e Saúde Coletiva, 25(1), 2395–2401. https://doi.org/10.1590/1413-81232020256.1.09632020
Kim, S., Jin, H. J., & Kim, S. R. (2020). Management of severe asthma during the COVID-19 pandemic in Korea. Allergy, Asthma & Immunology Research, 12(5), 897–901. https://doi.org/10.4168/aair.2020.12.5.897
Lenardt, M. H., & Carneiro, N. H. K. (2013). Associação entre as características sociodemográficas e a capacidade funcional de idosos longevos da comunidade. Cogitare Enfermagem, 18(1). https://doi.org/10.5380/ce.v18i1.31299
Mesenburg, M. A., Hallal, P. C., Menezes, A. M. B., Barros, A. J. D., Horta, B. L., Barros, F. C., Hartwig, F. P., Jacques, N., & Silveira, M. F. (2021). Chronic non-communicable diseases and COVID-19: EPICOVID-19 Brazil results. Revista De Saúde Pública, 55. https://doi.org/10.11606/s1518-8787.2021055003673
Moura, J. C. V., Moura, I. C. G., Gaspar, G. R., Mendes, G. M. S., Faria, B. A. V., Jentzsch, N. S., do Carmo Friche Passos, M., Kurdi, A., Godman, B., & Almeida, A. M. (2019). The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications. Clinics (Sao Paulo, Brazil), 74(e950), e950. https://doi.org/10.6061/clinics/2019/e950
Miranda, B. L., Silva, K. M. R., Barbosa, T. T., Lima, D., Barbosa, M. L., De M, R., Oliveira, J. C., Silva, H. J. N., Nascimento, A. C. O., Melo, S. M., Machado, K., Da, C., & Ferreira, K. L. C. (2021). Natural probiotics for the prevention and treatment of chronic diseases: A review. Research, Society and Development, 10(5). https://doi.org/10.33448/rsd-v10i5.14930
Nóbrega, C. F. D. S., & Simão, M. A. A. C. (2018). Doenças alérgicas respiratórias na ilha da Madeira. Master’s thesis.
Pires, L. N., Carvalho, L., & Xavier, L. D. L. (2020). e desigualdade: a distribuição dos fatores de risco no Brasil.
Pinto, B. G., Oliveira, A. E., Singh, Y., & Jimenez, L. (2019). A expressão de ACE2 é aumentada nos pulmões de pacientes com comorbidades associadas a COVID-19 grave. Medrxiv. https://doi.org/10.1101/2020.03.21.20040261
Portal da Secretaria de Atenção Primária a Saúde. (n.d.). APS. Retrieved November 28, 2022, from https://aps.saude.gov.br/ape/pics
Roncada, C., De Souza, R. G., Costa, D. D., & Pitrez, P. M. (2020). Asma pediátrica: impacto da doença em crianças em acompanhamento ambulatorial no Sul do Brasil. Revista Paulista de Pediatria. https://doi.org/10.1590/1984-0462/2020/38/2018398
Wang, C. J., Huang, S. W., & Chang, C. H. (2008). Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. Journal of Endourology, 22(1), 41–46. https://doi.org/10.1089/end.2007.0133
World Health Organization. (2020). Key planning recommendations for mass gatherings in the context of COVID-19: interim guidance, 19 March 2020. World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Gabriela Resende Tanque; Marileia Chaves Andrade; Victória Silva Capucci
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
